The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2)
Open accessAbstract
Mechanisms of drug resistance other than P-glycoprotein are of increasing interest as the list of newly identified members of the ABC transport family has grown. We sought to characterize the phenotype of the newly discovered ABC transporter encoded by the mitoxantrone resistance gene, MXR, also known as ABCP1 or BCRP. The pharmacodynamics of mitoxantrone and 12 other fluorescent drugs were evaluated by confocal microscopy in four multidrug-resistant human colon (S1) and breast (MCF-7) cancer cell lines. We utilized two sublines, MCF-7 AdVp3000 and S1-M1-80, and detected overexpression of MXR by PCR, immunoblot assay and immunohistochemistry. These MXR overexpressing sublines were compared to cell lines with P-glycoprotein- and MRP-mediated resistance. High levels of cross-resistance were observed for mitoxantrone, the anthracyclines, bisantrene and topotecan. Reduced levels of mitoxantrone, daunorubicin, bisantrene, topotecan, rhodamine 123 and prazosin were observed in the two sublines with high MXR expression. Neither the P-glycoprotein substrates vinblastine, paclitaxel, verapamil and calcein-AM, nor the MRP substrate calcein, were extruded from MCF-7 AdVp3000 and S1-M1-80 cells. Thus, the multidrug-resistant phenotype due to MXR expression is overlapping with, but distinct from, that due to P-glycoprotein. Further, cells that overexpress the MXR protein seem to be more resistant to mitoxantrone and topotecan than cells with P-glycoprotein-mediated multidrug resistance. Our studies suggest that the ABC half-transporter, MXR, is a potent, new mechanism for conferring multiple drug resistance. Definition of its mechanism of transport and its role in clinical oncology is required.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
The neighbor-joining method: a new method for reconstructing phylogenetic trees.
(1987) · Molecular Biology and Evolution · doi:10.1093/oxfordjournals.molbev.a040454 · Cited by 59,715
New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening
Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenney, S., & Boyd, M. R. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.13.1107 · Cited by 9,766
ABC Transporters: From Microorganisms to Man
Higgins, C. F. (1992) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.08.110192.000435 · Cited by 3,985
BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER
Gottesman, M. M., & Pastan, I. (1993) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.62.070193.002125 · Cited by 3,568
Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V., & Deeley, R. G. (1992) · Science · doi:10.1126/science.1360704 · Cited by 3,037
Handbook of fluorescent probes and research chemicals
Haugland, R. P. (1996) · Medical Entomology and Zoology · Cited by 2,793
A multidrug resistance transporter from human MCF-7 breast cancer cells
Doyle, L. A., Yang, W., Abruzzo, L. V., Krogmann, T., Gao, Y., Rishi, A. K., & Ross, D. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15665 · Cited by 2,322
Self-citationMiyake, K., Mickley, L. A., Litman, T., Zhan, Z., Robey, R. W., Cristensen, B., Brangi, M., Greenberger, L., Dean, M. C., Fojo, T., et al. (1999) · PubMed · Cited by 823
Self-citationAllikmets, R., Schriml, L. M., Hutchinson, A. A., Romano-Spica, V., & Dean, M. C. (1998) · PubMed · Cited by 798
Müller, M., Meijer, C., Zaman, G. J., Borst, P., Scheper, R. J., Mulder, N. H., de Vries, E. G., & Jansen, P. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.13033 · Cited by 617
The drug resistance-related protein LRP is the human major vault protein
Scheffer, G. L., Wijngaard, P. L. J., Flens, M. J., Izquierdo, M. A., Slovak, M. L., Pinedo, H. M., Meijer, C. J. L. M., Clevers, H. C., & Scheper, R. J. (1995) · Nature Medicine · doi:10.1038/nm0695-578 · Cited by 615
Multidrug resistance: molecular mechanisms and clinical relevance
Ling, V. (1997) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800051053 · Cited by 522
Fluorescent cellular indicators are extruded by the multidrug resistance protein.
Homolya, L., Holló, Z., Germann, U. A., Pastan, I., Gottesman, M. M., & Sarkadi, B. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80566-3 · Cited by 495
Reduced drug accumulation in multiply drug-resistant human KB carcinoma cell lines.
Fojo, A. T., Akiyama, S., Gottesman, M. M., et al. (1985) · PubMed · Cited by 435
Allikmets, R. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.10.1649 · Cited by 334
DNA sequence of the white locus of Drosophila melanogaster
O'Hare, K., Murphy, C., Levis, R., & Rubin, G. M. (1984) · Journal of Molecular Biology · doi:10.1016/0022-2836(84)90021-4 · Cited by 276
Schindler, M., Grabski, S., Hoff, E., & Simon, S. M. (1996) · Biochemistry · doi:10.1021/bi952234e · Cited by 269
Brangi, M., Litman, T., Ciotti, M., Nishiyama, K., Kohlhagen, G., Takimoto, C. H. M., Robey, R. W., Pommier, Y. G., Fojo, T., & Bates, S. E. (1999) · PubMed · Cited by 263
Self-citationEvolution of ATP-binding cassette transporter genes
Dean, M. (1995) · Current Opinion in Genetics & Development · doi:10.1016/0959-437x(95)80011-s · Cited by 245
Chen, Y. N., Mickley, L. A., Schwartz, A. M., Acton, E. M., Hwang, J. L., & Fojo, A. T. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38781-2 · Cited by 221
Mechanism of Acidification of the trans-Golgi Network (TGN)
Demaurex, N., Furuya, W., D'Souza, S., Bonifacino, J. S., & Grinstein, S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.4.2044 · Cited by 196
Lee, K., Belinsky, M. G., Bell, D. W., Testa, J. R., & Kruh, G. D. (1998) · PubMed · Cited by 149
Dietel, M., Arps, H., Lage, H., & Niendorf, A. (1990) · PubMed · Cited by 149
Almquist, K. C., Loe, D. W., Hipfner, D. R., Mackie, J. E., Cole, S. P. C., & Deeley, R. G. (1995) · PubMed · Cited by 146
Harker, W. G., Slade, D., Dalton, W. S., Meltzer, P. S., & Trent, J. M. (1989) · PubMed · Cited by 140
Nakagawa, M., Schneider, E., Dixon, K. H., Horton, J., Kelley, K., Morrow, C., & Cowan, K. H. (1992) · PubMed · Cited by 136
The transporters associated with antigen presentation
Townsend, A., & Trowsdale, J. (1993) · Seminars in Cell Biology · doi:10.1006/scel.1993.1007 · Cited by 117
The biology of the P-glycoproteins
Leveille-Webster, C., & Arias, I. M. (1995) · The Journal of Membrane Biology · doi:10.1007/bf00234655 · Cited by 115
Pharmacokinetics and Metabolism of Mitoxantrone
Ehninger, G., Schuler, U. S., Proksch, B., Zeller, K., & Blanz, J. (1990) · Clinical Pharmacokinetics · doi:10.2165/00003088-199018050-00003 · Cited by 112
Elferink, R. P. J. O., & Jansen, P. L. M. (1994) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)90034-5 · Cited by 105
Versantvoort, C. H. M., Bagrij, T., Wright, K. A., & Twentyman, P. R. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910630617 · Cited by 79
Cytogenetic and phenotypic analysis of a human colon carcinoma cell line resistant to mitoxantrone.
Dalton, W. S., Cress, A. E., Alberts, D. S., & Trent, J. M. (1988) · PubMed · Cited by 63
Future perspectives for the development of P-glycoprotein modulators
Sandor, V. A., Fojo, T., & Bates, S. E. (1998) · Drug Resistance Updates · doi:10.1016/s1368-7646(98)80039-3 · Cited by 63
Self-citationLonghurst, T., O’Neill, G. M., Harvie, R. M., & Davey, R. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.545 · Cited by 62
van Luyn, M. J. A., Müller, M., Renes, J., Meijer, C., Scheper, R. J., Nienhuis, E. F., Mulder, N. H., Jansen, P. L. M., & de Vries, E. G. E. (1998) · International Journal of Cancer · Cited by 62
The Role of Glucuronidation in 7‐Ethyl‐10‐hydroxycamptothecin Resistance in vitro
Takahashi, T., Fujiwara, Y., Yamakido, M., Katoh, O., Watanabe, H., & Mackenzie, P. I. (1997) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1997.tb00351.x · Cited by 54
Mantovani, G., Macciò, A., Pisano, M., Versace, R., Lai, P., Esu, S., Massa, E., Ghiani, M., Dessì, D., Melis, G. B., et al. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970529)71:5<817::aid-ijc20>3.0.co;2-3 · Cited by 45
Zhan, Z., Sandor, V. A., Gamelin, E. C., et al. (1997) · Blood · doi:10.1182/blood.v89.10.3795 · Cited by 32
Richard, B., Fabre, G., de Sousa, G., Fabre, I., Rahmani, R., & Cano, J. P. (1991) · Biochemical Pharmacology · doi:10.1016/0006-2952(91)90484-m · Cited by 31
Rekha, G. K., & Sládek, N. E. (1997) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050649 · Cited by 26
Fox, M. E., & Smith, P. J. (1995) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050254 · Cited by 22
Cited by
Targeting multidrug resistance in cancer
Szakács, G., Paterson, J. K., Ludwig, J. A., Booth-Genthe, C., & Gottesman, M. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1984 · Cited by 3,609
Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance
Yao, Y., Zhou, Y., Liu, L., Xu, Y., Chen, Q., Wang, Y., Wu, S., Deng, Y., Zhang, J., & Shao, A. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00193 · Cited by 1,451
Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)
Austin Doyle, L., & Ross, D. D. (2003) · Oncogene · doi:10.1038/sj.onc.1206938 · Cited by 1,051
Self-citationMechanisms of chemoresistance in cancer stem cells
Abdullah, L. N., & Chow, E. K. (2013) · Clinical and Translational Medicine · doi:10.1186/2001-1326-2-3 · Cited by 721
Litman, T., Druley, T. E., Stein, W. D., & Bates, S. E. (2001) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000912 · Cited by 688
Self-citation
Metadata
- Authors
- Litman, T., Brangi, M., Hudson, E., Fetsch, P., Abati, A., Ross, D. D., Miyake, K., Resau, J. H., & Bates, S. E.
- Venue
- Journal of Cell Science
- Publisher
- The Company of Biologists
- Published
- 2000-06-01
- Volume
- 113
- Issue
- 11
- Pages
- 2011-2021
- ISSN
- 0021-9533 (ISSN-L)
- 1477-9137
- OpenAlex
- W2168471377
- Cited by
- 538
- References
- 42
- FWCI
- 11.21
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.